Largeot, A., Klapp, V., Viry, E., Gonder, S., Fernandez Botana, I., Blomme, A., Benzarti, M., Pierson, S., Duculty, C., Marttila, P., Wierz, M., Gargiulo, E., Pagano, G., An, N., El Hachem, N., Perez Hermandez, D., Chakraborty, S., Ysebaert, L., François, J.-H., ... Moussay, E. (2023). Inhibition of MYC translation through targeting of the newly identified PHB-eIF4F complex as therapeutic strategy in CLL. Blood. doi:10.1182/blood.2022017839 |
cheli, Y., tulic, M., El Hachem, N., nottet, N., Jacquel, A., Gesson, M., Strub, T., bille, K., picard-gauci, A., montaudié, H., beranger, G., passeron, T., Close, P., Bertolotto, C., & ballotti, R. (2021). ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity. Molecular Cancer. doi:10.1186/s12943-020-01306-2 |
Rapino, F.* , ZHOU, Z.* , RONCERO SANCHEZ, A. M.* , Joiret, M., Seca, C., El Hachem, N., Valenti, G., Latini, S., Shostak, K., Geris, L., Li, P., Huang, G., Mazzucchelli, G., Baiwir, D., Desmet, C., Chariot, A., Georges, M., & Close, P. (2021). Wobble tRNA modification and hydrophilic amino acid patterns dictate protein fate. Nature Communications, 12 (1), 2170. doi:10.1038/s41467-021-22254-5 * These authors have contributed equally to this work. |
El Hachem, N., & Ballotti, R. (2018). Pro-tumoral function of HACE1. Oncoscience. |
El Hachem, N., & Ballotti, R. (2018). The pro-tumoral function of HACE1. Oncoscience. |
Rouaud, F., Hamouda-Tekaya, N., Cerezo, M., Abbe, P., Zangari, J., Hofman, V., Ohanna, M., Baharia, M., El Hachem, N., Benfodda, Z., Lebeau, A., Tuli, M., Hofman, P., Bertolotto, C., Passeron, T., Annicotte, J.-S., Ballotti, R., & Rocchi, S. (2018). E2F1 inhibition mediates cell death of metastatic melanoma. Cell Death and Disease. doi:10.1038/s41419-018-0566-1 |